GlassScriptPhysician profile
Jeffrey D Brown
NPI 1184699571
$2,050.92
in general payments reported to CMS, 2019-2025
12 companies · $525 in 2025
The $525 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $15.72 · 2021: $214 · 2022: $137 · 2023: $318 · 2024: $357 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Entertainment: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.33 |
| Entertainment | $122.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $524.83 | 2019-2025 | Precision7, Total30, Precision 1 |
| Coopervision INC. | $350.74 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $300.71 | 2019-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $190.74 | 2023-2024 | Tecnis Simplicity, Tecnis Iol |
| Bausch & Lomb Americas INC. | $171.40 | 2022-2025 | Infuse |
| Abb Con-Cise Optical Group LLC | $147.56 | 2019 | |
| Shire North American Group INC | $124.49 | 2019 | |
| Optos, INC. | $122.14 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.13 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.23 | 2021 | |
| Harrow Eye, LLC | $21.46 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $19.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.